Mobile Application and Pregnant Patient Knowledge

June 9, 2020 updated by: Allison Reid, University Hospitals Cleveland Medical Center

Impact of Mobile Application on Patient Knowledge of Pregnancy Topics

Randomized controlled trial to investigate the impact of a pregnancy-specific mobile phone application on the knowledge of specific pregnancy topics and guidelines.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Ohio
      • Cleveland, Ohio, United States, 44106
        • University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • 18 years of age or older at time of consent (or 16-17 years of age with guardian present)
  • Singleton gestation

Exclusion Criteria:

  • Inadequate knowledge of English language
  • Inability to read at or above 8th grade level
  • Prior diagnosis of eating disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Control
Behavioral: Mobile Phone Application Educational Resources
Mobile Phone Application Educational Resources
Experimental: Study
Behavioral: Mobile Phone Application Educational Resources
Mobile Phone Application Educational Resources
Behavioral: Mobile Phone Application GWG Tracker
Mobile Phone Application GWG Tracker

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pregnancy-specific topic/guideline questionnaire
Time Frame: Outcome assessed up to 23 weeks gestation
Number of participants who correctly answer
Outcome assessed up to 23 weeks gestation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pregnancy-specific questionnaire
Time Frame: Outcome assessed up to 23 weeks gestation
Description of general patient population knowledge of pregnancy-specific topics and guidelines.
Outcome assessed up to 23 weeks gestation
Gestational weight gain quantification
Time Frame: Outcome assessed through study completion, an average of 7 months
Quantify total gestational weight gain with and without intervention from final documented weight during pregnancy.
Outcome assessed through study completion, an average of 7 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospitals Cleveland Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2018

Primary Completion (Actual)

May 31, 2019

Study Completion (Actual)

June 30, 2019

Study Registration Dates

First Submitted

January 30, 2018

First Submitted That Met QC Criteria

February 25, 2018

First Posted (Actual)

March 2, 2018

Study Record Updates

Last Update Posted (Actual)

June 11, 2020

Last Update Submitted That Met QC Criteria

June 9, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 01-18-30

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on Mobile Phone Application Educational Resources

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe